DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Oncology Clinical Trial Monitor

Developed by DRG’s Oncology experts to aid the clinical decisions of Oncology companies

Oncology is exploding with innovation, excitement and opportunity. But the landscape is changing so rapidly that it’s often difficult for biopharmaceutical companies to stay on top of the market and make informed and successful investment decisions.


Oncology Clinical Trial Monitor helps companies access, visualize, and interpret data to uncover key trends in trial design and identify future pipeline opportunities in oncology.

Schedule a demo

Accurate, timely, and granular data


At the center of the product is a vast repository of data, capturing more than 50 key data points across thousands of oncology clinical trials. Instead of relying on automatic data pulls, our oncology experts collect, harmonize and interpret the information to ensure it is relevant and accurate. The data is updated weekly.

Customizable dashboard


The visualization dashboard represents a new standard of user interface for clinical database tools. Filters allow users to quickly and easily customize information based on a myriad of trial attributes including pipelines, trial design, trial burden, patient recruitment, treatment combinations, and emerging biomarkers pertaining to specific indications, product classes, companies – and to monitor these trends over time.

Oncology expertise


Our oncology experts are renowned analysts, thought leaders and advisers. They are involved in every stage of production, from building the data repository, choosing the data points, harmonizing and interpreting the data, designing the dashboard, and updating the database. As existing trusted partners in oncology, biopharma companies can rely our experts to interpret the most important data and insights from these trials.

Schedule a demo

The most valuable insights

Gain a competitive advantage with Oncology Clinical Trial Monitor:


  • Understand evolving markets and monitor competitive threats
  • Identify and evaluate appropriate acquisition targets and potential partners
  • Understand the development of biomarker stratification and how biomarkers might be used in clinical trial design
  • Identify new opportunities in untapped markets, aided by the creation of visual heatmaps
  • Learn how competitors design trials (recruitment, endpoints, burden)
  • Evaluate early emerging trends (from Phase 1 trials) for long-range forecasting


Oncology Clinical Trial Monitor enables companies to find fast answers to specific, highly nuanced questions and to create visual heatmaps of clinical activity, revealing areas of potential opportunities for investment. This tool has been designed exclusively for the oncology space, and offers all the functionality and search parameters you need, and none of the data clutter you don’t need. Contact us today to schedule a demo with one of DRG’S Oncology experts.

Schedule a demo

Case Studies

Understand the evolving IO landscape

A top 10 pharmaceutical company needs to stay informed of the shifting immuno-oncology landscape.


Prioritize early-phase development

A large pharma company is trying to prioritize its combination strategy in early-phase clinical trials for an emerging MEK inhibitor.


Design pivotal trials for optimal market access

Demonstrating meaningful improvements in relevant endpoints in appropriately designed trials will lower market access hurdles, but the goalposts are moving.


Identify emerging biomarkers in oncology

An emerging asset is not effective in a broad population. A leading biotech believes it will be effective in a sub-population, but is unsure which biomarkers are relevant.